Difference between revisions of "Lusutrombopag (Mulpleta)"
Jump to navigation
Jump to search
m (→Also known as) |
m |
||
| Line 6: | Line 6: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | * 2018-07-31: Approved for [[Thrombocytopenia in liver disease|thrombocytopenia in adults with chronic liver disease]] who are scheduled to undergo a medical or dental procedure. |
==Also known as== | ==Also known as== | ||
Revision as of 00:59, 7 May 2023
Mechanism of action
Thrombopoietin receptor agonist
Diseases for which it is used
History of changes in FDA indication
- 2018-07-31: Approved for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
Also known as
- Brand name: Mulpleo, Mulpleta